Moderna
MRNA
#221
Rank
S$131.59 B
Marketcap
S$325.24
Share price
5.27%
Change (1 day)
909.46%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -S$3.92 Billion

According to Moderna 's latest financial reports the company's current earnings are S$2.21 Billion. In 2025 the company made an earning of -S$3.53 Billion, an increase over its 2024 earnings that were of -S$4.59 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$3.92 Billion11.05%
2025 -S$3.53 Billion-23.03%
2024 -S$4.59 Billion-8.22%
2023 -S$5 Billion-140.65%
2022 S$12.28 B-27.81%
2021 S$17.02 B-1911.15%
2020 -S$0.94 Billion44.7%
2019 -S$0.65 Billion28.63%
2018 -S$0.51 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$23.95 B-714.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$16.17 B-515.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
S$9.83 B-352.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-S$60.69 Million-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-S$0.16 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-S$53.44 Million-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$1.56 B-140.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-S$0.21 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA